Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals

Biotechniques. 2021 Jul;71(1):370-375. doi: 10.2144/btn-2021-0044. Epub 2021 Jun 18.

Abstract

Inactivation of SARS-CoV-2 virus is necessary to mitigate risk but may interfere with diagnostic assay performance. We examined the effect of heat inactivation on a prototype SARS-CoV-2 antigen immunoassay run on the ARCHITECT automated analyzer. Recombinant full-length SARS-CoV-2 nucleocapsid protein and virus lysate detection was reduced by 66 and 31%, respectively. Several nonionic detergents were assessed as inactivation alternatives based on infectivity in cultured Vero CCL81 cells. Incubation of SARS-CoV-2 in 0.1% Tergitol 15-S-9 for 10 min significantly reduced infectivity and increased the immunoassay signal for cultured lysate and patient specimens. Tergitol 15-S-9 can inactivate SARS-CoV-2 while preserving epitopes on the nucleocapsid protein for enhanced detection by immunoassay antibodies.

Keywords: SARS-CoV-2; Tergitol 15-S-9; immunoassay; viral inactivation.

MeSH terms

  • Animals
  • Antibodies, Viral / drug effects
  • Antibodies, Viral / immunology
  • COVID-19 / diagnosis
  • COVID-19 / immunology
  • COVID-19 Testing / methods*
  • COVID-19 Testing / standards
  • Cells, Cultured
  • Chlorocebus aethiops
  • Humans
  • Immunoassay / methods
  • Immunoassay / standards
  • Nucleocapsid / immunology
  • Poloxalene / pharmacology*
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / immunology*
  • Surface-Active Agents / pharmacology
  • Vero Cells
  • Virus Inactivation / drug effects*

Substances

  • Antibodies, Viral
  • Surface-Active Agents
  • Poloxalene

Grants and funding